Initial studies that observed increased FGF21 levels associated with obesity hypothesized that this reflected a state of “FGF21 resistance”, due to modestly decreased expression levels of both KLB and FGFR1 in perigonadal WAT (33). The gene discussed is FGF21; the disease is Obesity.